Back in February, when South Africa was coming out of its second wave of the coronavirus, the Financial Times’ Joseph Cotterill wrote about the leading edge South African scientists and laboratories that had been developed for HIV and TB but repurposed for the pandemic, enabling the country to identify the Beta variant rapidly...